To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

ACUVUE® Portfolio

 

This framework is a quick tool to understand and differentiate ACUVUE® contact lenses.

 

ACUVUE® Eye Inspired Innovations

ACUVUE® Eye Inspired Innovations

 

ACUVUE® Portfolio Framework

ACUVUE® Portfolio Framework - Classic

 

ACUVUE® Portfolio Framework - Advanced

 

ACUVUE® Portfolio Framework - Optimum

 

Download a copy of the ACUVUE® framework

 

The framework shows our EYE-INSPIRED™ INNOVATIONS, which are advanced technologies designed to work in harmony with your patient’s eyes. This is followed by each ACUVUE® contact lens family with its benefits classified in three tiers: Classic, Advanced and Optimum.

 

 

* Survey among 150 Eye Care Professionals from the United Kingdom conducted from May 2021 to June 2021.
** Based on Comfort and Vision within our ACUVUE® portfolio.
*** 14 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST brand family (spherical, astigmatism, and multifocal) contact. Published trials include comparisons between etafilcon A and nelfilcon A, omafilcon A, hilafilcon B, ocufilcon D and nesofilcon A. Review conducted as of April 29, 2022.
^ ClinicalTrials.gov is a website maintained by the NIH. The 14 clinical studies evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST Brand family (spherical, astigmatism, and multifocal) contact lenses. Review conducted as of April 29, 2022. ClinicalTrials.gov is a website maintained by the NIH. The 17 clinical studies evaluated objective and subjective vision as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST brand family (spherical, astigmatism, and multifocal) contact lenses. Review conducted as of April 29, 2022.
† High intensity light/bright light/changing light found both indoors and outdoors.
§ All ACUVUE® contact lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens.
^^ ClinicalTrials.gov is a website maintained by the NIH. The 31 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-weekly family and for ACUVUE® OASYS 1-Day with HydraLuxe® Technology Brand family contact lenses. Review conducted as of April 29, 2022. Improved optical performance and vision compared to ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR® Plus Technology. The presence of PVP within the lens and on its surface results in a design with low pervaporation which helps to enable comfort during digital device use.
‡ ClinicalTrials.gov is a website maintained by the NIH. The 25 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-weekly family contact lenses. Review conducted as of April 29, 2022.
¥ Versus ACUVUE® OASYS 1-Day (ACUVUE® OASYS MAX 1-Day).
‡‡ 36.6% rated excellent and 38.4% rated very good (ACUVUE® OASYS MAX 1-Day MULTIFOCAL).
# Filtering of HEV light by contact lenses has not been demonstrated to confer any systemic and/or ocular health benefit to the user. The Eye Care Professional should be consulted for more information.

References

1. JJV Data on File 2020. ACUVUE® Brand - Eye-Inspired Innovations.
2. JJV Data on File 2016. 30-day dispensing evaluation, monthly replacement DW study, n=533 soft silicone hydrogel CL wearers in the U.S.
3. Canavan K, Sulley A, Coles-Brennan C, et al. Multi-Center Clinical Evaluation of Lapsed Wearers Refitted with senofilcon A Contact Lenses. Optom Vis Sci 2014;91:e-abstract 145180.
4. JJV Data on File 2017. Optical Precision of ACUVUE® OASYS Brand 1-Day Contact Lenses with HydraLuxe® Technology.
5. JJV Data on File 2021. ACUVUE® Brand Contact Lenses for ASTIGMATISM - Overall Fitting Success, Orientation Position, Rotational Stability, and Vision Performance.
6. JJV Data on File 2018. ACUVUE® Master Brand Claims on Clinical Performance and Overall Material Properties.
7. JJV Data on File 2021. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
8. JJV Data on File 2021. HydraLuxe® Technology Definition.
9. JJV Data on File 2016. 1-week dispensing evaluation, daily wear study, n=119 soft contact lens wearers in the United States.
10. JJV Data on File 2016. Single-masked, 2-visit, bilateral wear, single arm 1-week daily wear dispensing study of 162 US habitual toric soft contact lens wearers in both eyes, with a spherical distance refraction of -1.50D to -4.00D (inclusive), cylinder correction of 0.75D to 1.50D after vertex correction (inclusive), and refractive cylinder axis within 180±15 degrees or 90±15 degrees.
11. Cheng X, Moody K, Xu J, et al. Visual Performance of Silicone Hydrogel Daily Disposable Contact Lenses. Contact Lens Anterior Eye. 2018;41(S1):S70. https://doi.org/10.1016/j.clae.2018.03.093.
12. JJV Data on File 2021. ACUVUE® Brand Contact Lenses: PVP [poly(N-vinyl pyrrolidone)] and its Similarity to Mucin.
13. JJV Data on File 2018. Material Properties: ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR PLUS, ACUVUE® OASYS with Transitions™ Light Intelligent Technology™, and Other Reusable Contact Lenses.
14. JJV Data on File 2021. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye, and ACUVUE® OASYS 1-Day with HydraLuxe® Technology Brand Contact Lenses.
15. JJV Data on File 2015. Minimal Frictional Energy/Sliding Work with ACUVUE® OASYS 1-Day with HydraLuxe® Technology Brand Contact Lenses.
16. JJV Data on File, 2022. CSM Subjective Responses ACUVUE® OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis.
17. JJV Data on File 2022. Subjective Stand-Alone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses - Exploratory Meta-analysis.
18. JJV Data on File 2018. Definition of ACUVUE® OASYS with Transitions™ Light Intelligent Technology™.
19. JJV Data on File 2018. ACUVUE® OASYS Brand Contact Lenses with Transitions™ Light Intelligent Technology™ - Objective Clinical Claims.
20. JJV Data on File 2022. TearStable™ Technology Definition.

Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For complete information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use or visit our J&J website www.jnjvisionpro.co.uk

© Johnson & Johnson Medical Ltd 2022. ACUVUE®, ACUVUE® OASYS, 1-DAY ACUVUE® MOIST, ACUVUE® OASYS MAX 1-Day, ACUVUE® VITA™, ACUVUE® OASYS with Transitions™, HydraLuxe®, HYDRACLEAR®, Light Intelligent Technology™ and TearStable™ are registered trademarks of Johnson & Johnson.
PP2022MLT6244